Vera Therapeutics (VERA) Treasury Shares (2020 - 2026)

Vera Therapeutics' Treasury Shares history runs 7 years deep, the most recent figure standing at $2.1 million for Q1 2026.

• Quarterly Treasury Shares rose 83.26% year-over-year to $2.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.1 million (up 83.26% YoY) and the FY2025 annual result came in at $1.6 million, up 129.57% from the prior year.
• Treasury Shares was $2.1 million for Q1 2026 at Vera Therapeutics, up from $1.6 million in the prior quarter.
• Across five years, Treasury Shares topped out at $2.1 million in Q1 2026 and bottomed at $53860.0 in Q2 2022.
• A 5-year average of $654548.8 and a median of $472325.0 in 2024 frame the typical range for Treasury Shares.
• Peak annual rise in Treasury Shares reached 5584.8% in 2022, while the deepest fall reached 99.97% in 2022.
• Vera Therapeutics' Treasury Shares stood at $204000.0 in 2022, then tumbled by 35.45% to $131679.0 in 2023, then jumped by 429.23% to $696888.0 in 2024, then jumped by 129.57% to $1.6 million in 2025, then soared by 32.38% to $2.1 million in 2026.
• Business Quant data shows VERA's Treasury Shares at $2.1 million in Q1 2026, $1.6 million in Q4 2025, and $1.5 million in Q3 2025.